$SIGY News
Last published 6mo ago
- 6mo agoOGENSIGYOragenics Signs Letter of Intent to License CardioDialysis™ Technology from Sigyn Therapeutics to Target TBI-Induced Systemic InflammationGlobeNewswireThe Expected License Agreement Would Position Oragenics as the Only Company with Therapeutic Strategies Targeting TBI-Induced Inflammation on Both Sides of the Blood-Brain Barrier Sarasota, FL and San Diego, CA, May
- 1y agoACUTDRMAHMTXFINM+4Life Sciences Virtual Investor Forum: Presentations Now Available for Online ViewingGlobeNewswireNEW YORK, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Life Sciences Virtual Investor Forum, held
- 1y agoSIGYSigyn Therapeutics to Present at the Life Sciences Virtual Investor Forum on September 18thGlobeNewswireSAN DIEGO, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Sigyn Therapeutics, Inc. ("Sigyn" or the "Company") (OTCQB:SIGY), a developer of dialysis-like therapies to address cardiovascular disease and cancer, today announced that
- 1y agoBNAIBTQQFDTZNYILLMF+5Small Cap Growth Virtual Investor Conference: Presentations Now Available for Online ViewingGlobeNewswireNEW YORK, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Small Cap Growth Virtual Investor Conference,
- 1y agoSIGYSigyn Therapeutics to Present at Tomorrow's Small Cap Growth Virtual Investor ConferenceGlobeNewswireSAN DIEGO, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Sigyn Therapeutics, Inc. ("Sigyn" or the "Company") (OTCQB:SIGY), a developer of next-generation blood purification technologies to treat cancer and life-threatening
- 1y agoBNAIBTQQFDTZNYFDMIF+7Small Cap Growth Virtual Investor Conference Agenda Announced for February 6thGlobeNewswireNEW YORK, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series announced the agenda for the Small Cap Growth Virtual Investor Conference to be held February
- 2y agoSIGYSigyn Therapeutics Announces Reverse Stock SplitGlobeNewswireSAN DIEGO, CA, Jan. 30, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. ("Sigyn" or the "Company") (OTCQB:SIGY), a development-stage medical technology company, today announced that a 1-for-40
- 2y agoSIGYSigyn Therapeutics Releases Letter to ShareholdersGlobeNewswireSAN DIEGO, CA, Jan. 04, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. ("Sigyn" or the "Company") (OTCQB:SIGY), a development-stage medical technology company, today announced the release of a
- 2y agoSIGYSigyn Therapeutics Announces Appointment of Jerry DeCiccio as Chief Financial OfficerGlobeNewswireSAN DIEGO, CA, Dec. 12, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. ("Sigyn" or the "Company") (OTCQB:SIGY), a development-stage medical technology company, today announced the appointment of
- 2y agoSIGYSigyn Therapeutics Reports Third Quarter 2023 Financial ResultsGlobeNewswireSAN DIEGO, CA, Nov. 14, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire –Sigyn Therapeutics, Inc. ("Sigyn" or the "Company") (OTCQB:SIGY), a development-stage medical technology company, today announces financial results for
- 3y agoSIGYSigyn Therapeutics™ Discloses PCT Patent Submission to Enhance Chemotherapy Delivery and Reduce Cancer Treatment ToxicityGlobeNewswireSAN DIEGO, CA, Oct. 04, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. ("Sigyn" or the "Company") (OTCQB:SIGY), a development-stage medical technology company, today disclosed the submission of a
- 3y agoSIGYSigyn Therapeutics to Present at Today's Emerging Growth Conference and Tomorrow at the National Investment Bankers Association ConferenceGlobeNewswireSAN DIEGO, CA, Sept. 06, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Sigyn Therapeutics, Inc. ("Sigyn" or the "Company") (OTCQB:SIGY), a medical technology company that creates blood purification therapies to address
- 3y agoSIGYSigyn Therapeutics Reports Second Quarter 2023 Financial ResultsGlobeNewswireSAN DIEGO, CA, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Sigyn Therapeutics, Inc. ("Sigyn" or the "Company") (OTCQB:SIGY), a medical technology company that creates blood purification devices to overcome clearly defined
- 3y agoSIGYSigyn Therapeutics to Present at Tomorrow's Emerging Growth ConferenceGlobeNewswireSAN DIEGO, CA, Aug. 08, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. ("Sigyn" or the "Company") (OTCQB:SIGY), a medical technology company that creates blood purification devices to overcome
- 3y agoSIGYSigyn Therapeutics to Present at the OTCQB Venture Virtual Investor Conference on August 3rdGlobeNewswireSAN DIEGO, July 31, 2023 (GLOBE NEWSWIRE) -- Sigyn Therapeutics, Inc. ("Sigyn" or the "Company") (OTCQB:SIGY), a development-stage company that creates therapeutic blood purification candidates to overcome clearly
- 3y agoSIGYSigyn Therapeutics Discloses "DEVICES FOR ENHANCING THE ACTIVITY OF THERAPEUTIC ANTIBODIES" Patent Submission and Related ImmunePrep™ Trademark ApplicationGlobeNewswireSAN DIEGO, CA, May 17, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. ("Sigyn" or the "Company") (OTCQB:SIGY), a development-stage medical technology company, disclosed today that it has
- 3y agoSIGYSigyn Therapeutics™ Announces Appointment of Annette Marleau, Ph.D. as Chief Scientific OfficerGlobeNewswireSAN DIEGO, CA, April 11, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Sigyn Therapeutics, Inc. (OTCQB:SIGY) ("Sigyn Therapeutics" or the "Company"), a development-stage company focused on the creation of blood
- 3y agoSIGYSigyn Therapeutics Announces Filing of 2022 Annual Report on SEC Form 10-KGlobeNewswireSAN DIEGO, CA, March 31, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Sigyn Therapeutics, Inc. (OTCQB:SIGY) ("Sigyn Therapeutics" or the "Company"), a development-stage company that creates blood purification
- 3y agoSIGYSigyn Therapeutics Announces Third Quarter 2022 Financial ResultsGlobeNewswireSAN DIEGO, CA, Nov. 15, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Sigyn Therapeutics, Inc. ("Sigyn" or the "Company") (OTCQB:SIGY), a development-stage company focused on creating therapeutic solutions to address
- 4y agoSIGYSigyn Therapeutics™ Discloses Trademark Applications to Register ChemoPrep™ and ChemoPure™ for Devices to Enhance Cancer TherapyGlobeNewswireSAN DIEGO, CA, Oct. 13, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Sigyn Therapeutics, Inc. ("Sigyn" or the "Company") (OTCQB:SIGY), a development-stage company focused on creating therapeutic solutions to address
- 4y agoSIGYSigyn Therapeutics™ Strengthens Board of Directors With the Appointments of Richa Nand, Jim Dorst and Christopher WetzelGlobeNewswire- Independent Directors Bring Expertise in Intellectual Property, Finance, Healthcare Delivery, and More - SAN DIEGO, CA, Oct. 04, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Sigyn Therapeutics, Inc. ("Sigyn" or the "Company") (OTCQB:SIGY), a deve
- 4y agoSIGYSigyn Therapeutics Announces First-In-Human Clinical Strategy to Address Inflammation and Endotoxemia in End-Stage Renal Disease PatientsGlobeNewswireSAN DIEGO, CA, Sept. 14, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Sigyn Therapeutics, Inc. (OTCQB:SIGY), a development-stage company focused on the creation of therapeutic solutions that address unmet needs in global health, announced today that i
- 4y agoSIGYSigyn Therapeutics Announces Second Quarter 2022 Financial ResultsGlobeNewswireSAN DIEGO, CA, Aug. 15, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (OTCQB:SIGY), a development-stage company focused on the creation of therapeutic solutions that address unmet needs in global health, today announces its f
- 4y agoSIGYSigyn Therapeutics to Commence Trading on the OTCQB® Venture ExchangeGlobeNewswireSAN DIEGO, CA, Aug. 03, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Sigyn Therapeutics, Inc. (OTCQB:SIGY), a development-stage medical technology company focused on addressing unmet needs in global health, announces that its securities will commence
- 4y agoALRNBMCSINNDLVO+4CEO Presenting on the Emerging Growth Conference on January 5 Register NowGlobeNewswireMIAMI, Jan. 04, 2022 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth Companies and Markets announces the Schedule of the 22nd Emergi
- 5y agoAAZZFABIOACOGFACST+81Investor Summit Group Provides Update on Upcoming Q4 Virtual SummitGlobeNewswireNEW YORK, Nov. 05, 2021 (GLOBE NEWSWIRE) -- The Investor Summit Group, widely recognized for its reputation as the host of North America's largest independent investor conferences, will be hosting the upcoming Q4 Virtual Summit on November 16-17. The e
- 5y agoSIGYSigyn Therapeutics Announces Rapid Elimination of Hepatic Toxins from Human Blood PlasmaGlobeNewswireSAN DIEGO, CA, July 15, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Sigyn Therapeutics, Inc. (OTCMarkets: SIGY), a medical technology company focused on the treatment of sepsis and other life-threatening inflammatory conditions, today announced the c
- 5y agoSIGYSigyn Therapeutics Reports Preliminary Results of Hepatic Encephalopathy Toxin StudyGlobeNewswireSAN DIEGO, July 13, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (OTCMarkets: SIGY), a medical technology company focused on the treatment of sepsis and other life-threatening inflammatory conditions, today announced the comple
- 5y agoSIGYThe Evolution of Blood Purification Technologies to Treat Emerging Pandemic Threats, Including COVID-19GlobeNewswireWebinar Event to Be Held Tomorrow June 29th at 12pm Eastern / 9am Pacific Time SAN DIEGO, CA, June 28, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Sigyn Therapeutics, Inc. (OTCMarkets: SIGY), a medical technology company focused on the treatment o
- 5y agoSIGYSigyn Therapeutics Announces Virtual Presentation Today at the LD Micro Invitational ConferenceGlobeNewswireThe Presentation Will Occur at 5:30pm Eastern / 2:30pm Pacific Time SAN DIEGO, June 08, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (OTCMarkets: SIGY), a medical technology company focused on the treatment of sepsis and oth
- 5y agoSIGYSigyn Therapeutics Announces Corporate Update WebinarGlobeNewswireThe Event Occurs Friday, May 21st at 11am Eastern / 8am Pacific Time SAN DIEGO, May 18, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (OTCMarkets: SIGY), a medical technology company focused on the treatment of life-threateni
- 5y agoSIGYSigyn Therapeutics™ Discloses In-Vitro Viral Pathogen StudyGlobeNewswireSigyn Therapy™ demonstrates the ability to address viral pathogens, including SARS-CoV-2 (COVID-19) SAN DIEGO, April 21, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (OTCMarkets: SIGY), a medical technology company fo
- 5y agoSIGYThe Closing Bell Featuring Sigyn TherapeuticsGlobeNewswireThe Interactive Videoconference Occurs Today at 4pm Eastern / 1pm Pacific Time SAN DIEGO, April 21, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (OTCMarkets: SIGY), a medical technology company focused on the treatment of li